US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis-Reference-Cited by-同舟云学术

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

Published:2016-03 Issue:2 Volume:15 Page:139-140
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Flume Patrick A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference7 articles.

1. Molecular epidemiology of Mycobacterium abscessus complex isolates in Ireland;O'Driscoll;J. Cyst. Fibros.,2016

2. A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis;Preece;J. Cyst. Fibros.,2016

3. The growing threat of nontuberculous mycobacteria in CF;Floto;J. Cyst. Fibros.,2015

4. Scandinavian Cystic Fibrosis Study Consortium (SCFSC). Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia;Qvist;J. Cyst. Fibros.,2015

5. Increasing nontuberculous mycobacteria infection in cystic fibrosis;Bar-On;J. Cyst. Fibros.,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren;Antimicrobial Agents and Chemotherapy;2022-06-21

2. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection;Antimicrobial Agents and Chemotherapy;2022-01-18

3. Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors;ACS Infectious Diseases;2021-06-30

4. β-Lactam Combinations That Exhibit Synergy against Mycobacteroides abscessus Clinical Isolates;Antimicrobial Agents and Chemotherapy;2021-03-18

5. Gram negative infections in cystic fibrosis: a review of preventative and treatment options;Expert Opinion on Orphan Drugs;2020-01-02